TTYH2 and cancer: They also found that TTYH1 and TTYH2 can generate VRAC currents independently in cancer cells after observing VRAC currents in the HepG2 cell line—which expresses only TTYH1—and in the LoVo cancer cell line—which expresses only TTYH2 (Bae et al., 2019).